CN106166290A - A kind of Chinese herbs paste treating infantile pneumonia - Google Patents
A kind of Chinese herbs paste treating infantile pneumonia Download PDFInfo
- Publication number
- CN106166290A CN106166290A CN201610832926.6A CN201610832926A CN106166290A CN 106166290 A CN106166290 A CN 106166290A CN 201610832926 A CN201610832926 A CN 201610832926A CN 106166290 A CN106166290 A CN 106166290A
- Authority
- CN
- China
- Prior art keywords
- patch
- cortex phellodendri
- moulding material
- herba
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Abstract
The present invention relates to a kind of Chinese herbs paste treating infantile pneumonia, can effectively solve existing medicine big to infantile pneumonia treatment side effect, Transdermal absorption is poor, the problem of the easy allergy of children's's skin.The technical scheme solved is that Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis are mixed extraction volatile oil;Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A mix manufacture of pharmaceutical components A;Take Cortex Phellodendri and prepare alkaloid;Take drug component A, medical polypropylene acid sodium, sodium carboxymethyl cellulose, pharmagel, tragacanth, water are mixed and made into patch moulding material I;Separately take Cortex Phellodendri alkaloid extract, volatile oil, carbomer, water make patch moulding material II;Patch moulding material II and patch moulding material I are mixed and made into patch, the Chinese herbs paste of infantile pneumonia must be treated.Compatibility of the present invention is reasonable, determined curative effect, and life-time service side effect is little, and water content is high, and without allergic phenomena, economic and social benefit is notable.
Description
Technical field
The present invention relates to field of medicaments, a kind of Chinese herbs paste treating infantile pneumonia.
Background knowledge
Infantile pneumonia is by pathogenic infection or to suck the pneumonia caused by amniotic fluid and oils and anaphylaxis etc., main
Wanting clinical manifestation is heating, cough, rapid breathing, dyspnea and pulmonary's sound etc..Infantile pneumonia is also children's acute heat
One of modal disease in disease, is in Pediatric Clinic and inpatient's number is the first, the most substantial amounts of in therapeutic process
Application antibiotics, not only medical expense height further increases the misery of infant, and usually makes virus and mycoplasma pneumoniae
Produce endurance strain, immune dysfunction energy harmful effect.
For solving problems, through a large amount of clinical practices, applicant finds that Chinese medicine external has in terms of preventing and treating infantile pneumonia
Good efficacy.Acupoint application of Chinese herb treatment disease of cough and asthma, makes drug percutaneous penetrate, through acupuncture point going from the exterior into the interior, reaches dirty in following meridians
Internal organs, with regulation negative and positive of qi and blood balance, reaches to treat the purpose of disease.Numerous studies show, children's's subcutaneous fat is few, and thoracic wall is thin, easily
In the absorption of percutaneous dosing, therefore the present invention uses Chinese medicine compound to make the external use plaster of percutaneous dosing for treating Lungs of Children
Scorching.Owing to children's bears a pretty, delicate skin easy allergy, the present invention is with hydrophilic high molecular material as substrate, it is to avoid use tradition
The stimulation to skin of the traditional fat-soluble substrate such as rubber-emplastrum, hot-fusible pressure-sensitive adhesive, the most less phenomena of cutaneous irritation.In order to
Solving the difficult problem that percutaneous absorbtion is difficult to absorb, the present invention is classified extracting separating treatment to Chinese medicine compound, to the full extent
The effective ingredient remaining prescription solves the problem that percutaneous dosing absorption efficiency is low simultaneously, considerably increases drug effect.
For the problems referred to above, present invention research also proposes a kind of Chinese herbs paste treating infantile pneumonia.
Summary of the invention
For above-mentioned situation, for solving the defect of prior art, the purpose of the present invention is just to provide one and treats Lungs of Children
Scorching Chinese herbs paste, side effect is big to infantile pneumonia treatment cycle length can effectively to solve existing medicine, and existing patch transdermal is inhaled
Astigmat, the problems such as drug effect is low, children's's easy allergy of skin.
The technical scheme is that, a kind of Chinese herbs paste treating infantile pneumonia, by the material medicine of following weight meter
Make: Cortex Magnoliae Officinalis 70-80g, 70-80g Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae) 70-80g, Bulbus Fritillariae Thunbergii 70-80g, Flos Farfarae 70-80g, Caulis Lonicerae 70-
80g, Herba Solani Nigri 70-80g, Rhizoma Zingiberis 70-80g, Cortex Phellodendri 90-100g, Flos Caryophylli 60-70g, Radix Bupleuri 70-80g, Herba Houttuyniae 80-90g, Herba Menthae
60-70g, wherein, mixes Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis, extracts volatilization with supercritical fluid extraction
Oil, concretely comprises the following steps: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis mixing, pulverize, put into supercritical extraction unit, according to
Lower condition extracts: extraction temperature 38 DEG C, extracting pressure 20MPa, extraction time 120min, CO2Flow 17L/h, extraction gained is waved
Hair oil is standby, and gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A
Mix, add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A weight 10-16 times amount
Volumetric concentration is the ethanol of 70%-95%, extracts 2 times with flash extracter, each 1-3min, filters, and merging filtrate, 50 DEG C subtract
It is 1.06-1.12 that pressure is concentrated into proportion, and lyophilization obtains drug component A, standby;Take Cortex Phellodendri pulverizing medicinal materials, add Cortex Phellodendri medical material
The ethanol solution that pH2.5 volumetric concentration is 50% of weight 15 times 25 DEG C soaks 8h, 95 DEG C of reflux, extract, 3h, filters, and filtrate subtracts
It is 1.08-1.15 that pressure is concentrated into proportion, and storng-acid cation exchange resin on concentrated solution, with the volumetric concentration containing 1mol/L ammonia
Be 70% ethanol solution carry out eluting, eluent is adjusted to pH6.5, concentrating under reduced pressure, lyophilization with hydrochloric acid, obtains Cortex Phellodendri alkaloid
Extract, standby;Take drug component A to be dissolved in the ethanol that volumetric concentration is 5% and make the drug component A that mass concentration is 7%
Solution, is sequentially added into medical polypropylene acid sodium, sodium carboxymethyl cellulose, pharmagel, tragacanth, water mix homogeneously, makes patch
Agent moulding material I;Separately take Cortex Phellodendri alkaloid extract and be dissolved in the ethanol that volumetric concentration is 8% that to make mass concentration be 5%
Cortex Phellodendri alkaloid solution, sequentially adds volatile oil, carbomer, water are sufficiently mixed uniformly, make patch moulding material II;Will patch
Agent moulding material II is mixed homogeneously and the most swelling with the quality ratio of 3.2:1 with patch moulding material I, makes patch, must control
Treat the Chinese herbs paste of infantile pneumonia;
The moulding material I of described patch is by following mass percent: drug component solution A 8.5%-13.5%,
Medical polypropylene acid sodium 11%-16%, sodium carboxymethyl cellulose 2%-5.1%, pharmagel 2.2%-5.1%, tragacanth
1.3%-2.1%, surplus is water, and total amount 100% forms;Patch moulding material II is by following mass percent: Cortex Phellodendri
Alkaloid solution 3%-5%, volatile oil 1%-5%, carbomer 19.3%-27.6%, surplus is water, and total amount 100% forms.
Compatibility of the present invention is reasonable, determined curative effect, and life-time service side effect is little, and water content is high, without allergic phenomena, processing technology
Simple, materials environmental protection, is the innovation on the Chinese herbs paste for the treatment of infantile pneumonia.
Detailed description of the invention:
Below in conjunction with embodiment, the detailed description of the invention of the present invention is described in further detail.
Embodiment 1
The present invention in the specific implementation, can be made up of the material medicine of following weight meter: Cortex Magnoliae Officinalis 71g, 71g Radix Ophiopogonis, Semen Lepidii
Sub-71g, Bulbus Fritillariae Thunbergii 71g, Flos Farfarae 71g, Caulis Lonicerae 71g, Herba Solani Nigri 71g, Rhizoma Zingiberis 71g, Cortex Phellodendri 91g, Flos Caryophylli 61g, Radix Bupleuri 71g,
Herba Houttuyniae 81g, Herba Menthae 61g, wherein, mix Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis, extracts with supercritical fluid
Follow the example of extraction volatile oil, concretely comprise the following steps: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis mixing, pulverize, put into supercritical extraction
Fetching is put, and extracts according to following condition: extraction temperature 38 DEG C, extracting pressure 20MPa, extraction time 120min, CO2Flow 17L/
H, extraction gained volatile oil is standby, and gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Radix Ophiopogonis
Rattan, Herba Solani Nigri, medicinal residues A mix, and add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A weight
The ethanol that volumetric concentration is 70%-95% of amount 10-16 times amount, extracts 2 times with flash extracter, each 1-3min, filters, and closes
And filtrate, 50 DEG C are evaporated to proportion is 1.06-1.12, lyophilization, obtains drug component A, standby;Take Cortex Phellodendri medical material powder
Broken, the ethanol solution that pH2.5 volumetric concentration is 50% 25 DEG C adding Cortex Phellodendri medical material weight 15 times soaks 8h, 95 DEG C of reflux, extract,
3h, filters, and filtrate reduced in volume to proportion is 1.08-1.15, storng-acid cation exchange resin on concentrated solution, with containing 1mol/L
The volumetric concentration of ammonia be 70% ethanol solution carry out eluting, eluent is adjusted to pH6.5 with hydrochloric acid, concentrating under reduced pressure, freezing dry
Dry, obtain Cortex Phellodendri alkaloid extract, standby;Take drug component A to be dissolved in and mass concentration made by the ethanol that volumetric concentration is 5% be
The drug component solution A of 7%, be sequentially added into medical polypropylene acid sodium, sodium carboxymethyl cellulose, pharmagel, tragacanth, water mix
Close uniformly, make patch moulding material I;Separately take Cortex Phellodendri alkaloid extract to be dissolved in the ethanol that volumetric concentration is 8% and make matter
Amount concentration is the Cortex Phellodendri alkaloid solution of 5%, sequentially adds volatile oil, carbomer, water are sufficiently mixed uniformly, make patch one-tenth
Shaped material II;Patch moulding material II is mixed homogeneously and the most swelling with the quality ratio of 3.2:1 with patch moulding material I, system
Become patch, the Chinese herbs paste of infantile pneumonia must be treated;
The moulding material I of described patch is by following mass percent: drug component solution A 8.5%, medicinal poly-third
Olefin(e) acid sodium 11%, sodium carboxymethyl cellulose 2%, pharmagel 2.2%, tragacanth 1.3%, surplus is water, total amount 100% group
Become;Patch moulding material II is by following mass percent: Cortex Phellodendri alkaloid solution 3%, volatile oil 1%, carbomer
19.3%, surplus is water, and total amount 100% forms.
Embodiment 2
The present invention in the specific implementation, can be made up of the material medicine of following weight meter: Cortex Magnoliae Officinalis 75g, 75g Radix Ophiopogonis, Semen Lepidii
Sub-75g, Bulbus Fritillariae Thunbergii 75g, Flos Farfarae 75g, Caulis Lonicerae 75g, Herba Solani Nigri 75g, Rhizoma Zingiberis 75g, Cortex Phellodendri 95g, Flos Caryophylli 65g, Radix Bupleuri 75g,
Herba Houttuyniae 85g, Herba Menthae 65g, wherein, mix Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis, extracts with supercritical fluid
Follow the example of extraction volatile oil, concretely comprise the following steps: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis mixing, pulverize, put into supercritical extraction
Fetching is put, and extracts according to following condition: extraction temperature 38 DEG C, extracting pressure 20MPa, extraction time 120min, CO2Flow 17L/
H, extraction gained volatile oil is standby, and gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Radix Ophiopogonis
Rattan, Herba Solani Nigri, medicinal residues A mix, and add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A weight
The ethanol that volumetric concentration is 70%-95% of amount 10-16 times amount, extracts 2 times with flash extracter, each 1-3min, filters, and closes
And filtrate, 50 DEG C are evaporated to proportion is 1.06-1.12, lyophilization, obtains drug component A, standby;Take Cortex Phellodendri medical material powder
Broken, the ethanol solution that pH2.5 volumetric concentration is 50% 25 DEG C adding Cortex Phellodendri medical material weight 15 times soaks 8h, 95 DEG C of reflux, extract,
3h, filters, and filtrate reduced in volume to proportion is 1.08-1.15, storng-acid cation exchange resin on concentrated solution, with containing 1mol/L
The volumetric concentration of ammonia be 70% ethanol solution carry out eluting, eluent is adjusted to pH6.5 with hydrochloric acid, concentrating under reduced pressure, freezing dry
Dry, obtain Cortex Phellodendri alkaloid extract, standby;Take drug component A to be dissolved in and mass concentration made by the ethanol that volumetric concentration is 5% be
The drug component solution A of 7%, be sequentially added into medical polypropylene acid sodium, sodium carboxymethyl cellulose, pharmagel, tragacanth, water mix
Close uniformly, make patch moulding material I;Separately take Cortex Phellodendri alkaloid extract to be dissolved in the ethanol that volumetric concentration is 8% and make matter
Amount concentration is the Cortex Phellodendri alkaloid solution of 5%, sequentially adds volatile oil, carbomer, water are sufficiently mixed uniformly, make patch one-tenth
Shaped material II;Patch moulding material II is mixed homogeneously and the most swelling with the quality ratio of 3.2:1 with patch moulding material I, system
Become patch, the Chinese herbs paste of infantile pneumonia must be treated;
The moulding material I of described patch is by following mass percent: drug component solution A 11.5%, medicinal poly-
Sodium acrylate 14%, sodium carboxymethyl cellulose 3.5%, pharmagel 3.5%, tragacanth 1.6%, surplus is water, total amount 100%
Composition;Patch moulding material II is by following mass percent: Cortex Phellodendri alkaloid solution 4%, volatile oil 3%, carbomer
23.5%, surplus is water, and total amount 100% forms.
Embodiment 3
The present invention in the specific implementation, can be made up of the material medicine of following weight meter: Cortex Magnoliae Officinalis 79g, 79g Radix Ophiopogonis, Semen Lepidii
Sub-79g, Bulbus Fritillariae Thunbergii 79g, Flos Farfarae 79g, Caulis Lonicerae 79g, Herba Solani Nigri 79g, Rhizoma Zingiberis 79g, Cortex Phellodendri 99g, Flos Caryophylli 69g, Radix Bupleuri 79g,
Herba Houttuyniae 89g, Herba Menthae 69g, wherein, mix Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis, extracts with supercritical fluid
Follow the example of extraction volatile oil, concretely comprise the following steps: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis mixing, pulverize, put into supercritical extraction
Fetching is put, and extracts according to following condition: extraction temperature 38 DEG C, extracting pressure 20MPa, extraction time 120min, CO2Flow 17L/
H, extraction gained volatile oil is standby, and gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Radix Ophiopogonis
Rattan, Herba Solani Nigri, medicinal residues A mix, and add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A weight
The ethanol that volumetric concentration is 70%-95% of amount 10-16 times amount, extracts 2 times with flash extracter, each 1-3min, filters, and closes
And filtrate, 50 DEG C are evaporated to proportion is 1.06-1.12, lyophilization, obtains drug component A, standby;Take Cortex Phellodendri medical material powder
Broken, the ethanol solution that pH2.5 volumetric concentration is 50% 25 DEG C adding Cortex Phellodendri medical material weight 15 times soaks 8h, 95 DEG C of reflux, extract,
3h, filters, and filtrate reduced in volume to proportion is 1.08-1.15, storng-acid cation exchange resin on concentrated solution, with containing 1mol/L
The volumetric concentration of ammonia be 70% ethanol solution carry out eluting, eluent is adjusted to pH6.5 with hydrochloric acid, concentrating under reduced pressure, freezing dry
Dry, obtain Cortex Phellodendri alkaloid extract, standby;Take drug component A to be dissolved in and mass concentration made by the ethanol that volumetric concentration is 5% be
The drug component solution A of 7%, be sequentially added into medical polypropylene acid sodium, sodium carboxymethyl cellulose, pharmagel, tragacanth, water mix
Close uniformly, make patch moulding material I;Separately take Cortex Phellodendri alkaloid extract to be dissolved in the ethanol that volumetric concentration is 8% and make matter
Amount concentration is the Cortex Phellodendri alkaloid solution of 5%, sequentially adds volatile oil, carbomer, water are sufficiently mixed uniformly, make patch one-tenth
Shaped material II;Patch moulding material II is mixed homogeneously and the most swelling with the quality ratio of 3.2:1 with patch moulding material I, system
Become patch, the Chinese herbs paste of infantile pneumonia must be treated;
The moulding material I of described patch is by following mass percent: drug component solution A 13.5%, medicinal poly-
Sodium acrylate 16%, sodium carboxymethyl cellulose 5.1%, pharmagel 5.1%, tragacanth 2.1%, surplus is water, total amount 100%
Composition;Patch moulding material II is by following mass percent: Cortex Phellodendri alkaloid solution 5%, volatile oil 5%, carbomer
27.6%, surplus is water, and total amount 100% forms.
Embodiment 4
The present invention in the specific implementation, can be made up of the material medicine of following weight meter: Cortex Magnoliae Officinalis 78g, 72g Radix Ophiopogonis, Semen Lepidii
Sub-76g, Bulbus Fritillariae Thunbergii 73g, Flos Farfarae 77g, Caulis Lonicerae 79g, Herba Solani Nigri 71g, Rhizoma Zingiberis 72g, Cortex Phellodendri 98g, Flos Caryophylli 66g, Radix Bupleuri 76g,
Herba Houttuyniae 87g, Herba Menthae 63g, wherein, mix Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis, extracts with supercritical fluid
Follow the example of extraction volatile oil, concretely comprise the following steps: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis mixing, pulverize, put into supercritical extraction
Fetching is put, and extracts according to following condition: extraction temperature 38 DEG C, extracting pressure 20MPa, extraction time 120min, CO2Flow 17L/
H, extraction gained volatile oil is standby, and gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Radix Ophiopogonis
Rattan, Herba Solani Nigri, medicinal residues A mix, and add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A weight
The ethanol that volumetric concentration is 70%-95% of amount 10-16 times amount, extracts 2 times with flash extracter, each 1-3min, filters, and closes
And filtrate, 50 DEG C are evaporated to proportion is 1.06-1.12, lyophilization, obtains drug component A, standby;Take Cortex Phellodendri medical material powder
Broken, the ethanol solution that pH2.5 volumetric concentration is 50% 25 DEG C adding Cortex Phellodendri medical material weight 15 times soaks 8h, 95 DEG C of reflux, extract,
3h, filters, and filtrate reduced in volume to proportion is 1.08-1.15, storng-acid cation exchange resin on concentrated solution, with containing 1mol/L
The volumetric concentration of ammonia be 70% ethanol solution carry out eluting, eluent is adjusted to pH6.5 with hydrochloric acid, concentrating under reduced pressure, freezing dry
Dry, obtain Cortex Phellodendri alkaloid extract, standby;Take drug component A to be dissolved in and mass concentration made by the ethanol that volumetric concentration is 5% be
The drug component solution A of 7%, be sequentially added into medical polypropylene acid sodium, sodium carboxymethyl cellulose, pharmagel, tragacanth, water mix
Close uniformly, make patch moulding material I;Separately take Cortex Phellodendri alkaloid extract to be dissolved in the ethanol that volumetric concentration is 8% and make matter
Amount concentration is the Cortex Phellodendri alkaloid solution of 5%, sequentially adds volatile oil, carbomer, water are sufficiently mixed uniformly, make patch one-tenth
Shaped material II;Patch moulding material II is mixed homogeneously and the most swelling with the quality ratio of 3.2:1 with patch moulding material I, system
Become patch, the Chinese herbs paste of infantile pneumonia must be treated;
The moulding material I of described patch is by following mass percent: drug component solution A 8.7%, medicinal poly-third
Olefin(e) acid sodium 15%, sodium carboxymethyl cellulose 2.2%, pharmagel 5.0%, tragacanth 1.4%, surplus is water, total amount 100% group
Become;Patch moulding material II is by following mass percent: Cortex Phellodendri alkaloid solution 3%, volatile oil 4.8%, carbomer
19.5%, surplus is water, and total amount 100% forms.
One, Chinese medicine patch of the present invention has carried out series of experiments according to country's new drug approval regulation, all achieves satisfied skill
Art effect, related experiment data is as follows:
1, acute toxicity test:
Take Cavia porcellus 60, random packet, depilation, the experiment of external Chinese herbs paste of the present invention, successive administration 15 days;Result: globefish
Pindone is whole and none animal dead of big small dose group of damaged skin, each activity organizing Cavia porcellus, defecation, and mental status etc. is the most just
Often, damaged skin NIP, oozing of blood etc. react, and also do not find obvious whole body toxicity, Chinese medicine prepared by the present invention is described
Patch application safety.
2, Skin Irritation Test:
Chinese herbs paste prepared by the present invention to Cavia porcellus intact skin without obvious irritation;To damaged skin zest relatively
Little, there is not erythema, infection or the skin irritation phenomenon such as redness, edema in local.
3, hypersensitive test:
Taking Cavia porcellus 50, male and female half and half, random packet is tested;Result: use aqueous Chinese medicine patch prepared by the present invention
After agent, the hair color of Cavia porcellus, the mental status etc. does not has abnormal phenomena, illustrates that Chinese herbs paste prepared by the present invention does not produce allergy existing
As.
4, long term toxicity test:
Cavia porcellus continuous use 90 days;Result: Chinese herbs paste of the present invention is to the hair of Cavia porcellus, behavior, defecation, body weight, dirty
The indexs such as the amount of thinking highly of, hemogram, hepatic and renal function, blood glucose, blood fat all have no significant effect.Histological examination shows, medication 90 days and stopping
After medicine 2 weeks, each internal organs of Cavia porcellus are all without obvious Histological change.Cavia porcellus performance the most without exception is respectively organized, OK during medication and after drug withdrawal
For vivaciously, ingesting normal, defecation is without exception.Illustrate that aqueous Chinese herbs paste prepared by the present invention is without long term toxicity, application safety.
Two, in order to prove that Chinese medicine patch of the present invention can be effective to treat infantile pneumonia, and there is effective effect, carry out
Clinical verification experiment, specific as follows:
1, case clinic selection standard:
" the Chinese medical disease Standardization of diagnosis and curative effect " issued according to traditional chinese medical science administration of country, is randomly divided into treatment group and compares
Group, treatment group 80 example, male 36 examples, female 44 example;Matched group 80 example, male 35 examples, female 45 example;Two groups of ages all in 2-10 year, in year
Age, course of disease aspect there was no significant difference (P > 0.05).
2, therapeutic scheme: matched group uses routine clinical treatment.Treatment group: on the basis for the treatment of of control group, at bilateral
Fei shu, region below the heart, Dingchuan, Danzhong acupuncture point lose money in a business invention aqueous Chinese medicine patch, paste 24h, every day 1 time every time, add up curative effect after 7 days.
3, criterion of therapeutical effect:
Clinical recovery: body temperature, cough, expectoration and pulmonary's sound recover normal, other clinical symptom disappearance;
Effective: temperature recovery is normal, cough, expectoration and pulmonary's sound significantly take a turn for the better (or level before acute attack);
Effective: body temperature, cough, expectoration and pulmonary's sound take a favorable turn, other transference cures or improvement, but degree is not as good as effective;
Invalid: body temperature, cough, expectoration pulmonary sound are without changing or increasing the weight of, and other clinical symptoms are many without improving or increasing the weight of.
4, clinical efficacy statistics:
Table 1 general curative effect compares
* P < 0.05 is compared with matched group
Table 2 treatment after cardinal symptom improve the time compare (Unit: sky)
* P < 0.05 is compared with matched group
From data above, the effective percentage for the treatment of group apparently higher than matched group, and fever time, cough and expectoration disappear time
Between, the index treatment group such as pulmonary's sound improvement time be superior to matched group.
5, conclusion
Clinical experiment shows, Chinese medicine patch of the present invention uses safety, does not occurs local skin pruritus, redness, allergy in test
Etc. phenomenon, the total effective rate of children Streptococcus is reached 96.25%, substantially reduce treatment time with combining of conventional therapy means
Improve therapeutic effect, be the innovation on the Chinese herbs paste for the treatment of infantile pneumonia, there is the clinical meaning of reality and push away widely
Wide using value.
Claims (5)
1. the Chinese herbs paste treating infantile pneumonia, it is characterised in that be made up of the material medicine of following weight meter: Cortex Magnoliae Officinalis
70-80g, 70-80g Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae) 70-80g, Bulbus Fritillariae Thunbergii 70-80g, Flos Farfarae 70-80g, Caulis Lonicerae 70-80g, Herba Solani Nigri 70-
80g, Rhizoma Zingiberis 70-80g, Cortex Phellodendri 90-100g, Flos Caryophylli 60-70g, Radix Bupleuri 70-80g, Herba Houttuyniae 80-90g, Herba Menthae 60-70g, its
In, Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis are mixed, extracts volatile oil with supercritical fluid extraction, specifically walk
Suddenly it is: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, Rhizoma Zingiberis mixing, pulverize, put into supercritical extraction unit, extract according to following condition
Take: extraction temperature 38 DEG C, extracting pressure 20MPa, extraction time 120min, CO2Flow 17L/h, extraction gained volatile oil is standby,
Gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A are blended in one
Rise, add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, the volumetric concentration of medicinal residues A weight 10-16 times amount
For the ethanol of 70%-95%, extracting 2 times with flash extracter, each 1-3min, filter, merging filtrate, 50 DEG C are evaporated to
Proportion is 1.06-1.12, lyophilization, obtains drug component A, standby;Take Cortex Phellodendri pulverizing medicinal materials, add Cortex Phellodendri medical material weight 15 times
The ethanol solution that pH2.5 volumetric concentration is 50% 25 DEG C soak 8h, 95 DEG C of reflux, extract, 3h, filter, filtrate reduced in volume is extremely
Proportion is 1.08-1.15, storng-acid cation exchange resin on concentrated solution, is 70% with the volumetric concentration containing 1mol/L ammonia
Ethanol solution carries out eluting, and eluent is adjusted to pH6.5, concentrating under reduced pressure, lyophilization with hydrochloric acid, obtains Cortex Phellodendri alkaloid extract,
Standby;Take drug component A to be dissolved in the ethanol that volumetric concentration is 5% and make the drug component solution A that mass concentration is 7%, depend on
Secondary addition medical polypropylene acid sodium, sodium carboxymethyl cellulose, pharmagel, tragacanth, water mix homogeneously, make patch forming material
Material I;Separately take Cortex Phellodendri alkaloid extract and be dissolved in the ethanol that volumetric concentration is 8% that to make Cortex Phellodendri that mass concentration is 5% biological
Aqueous slkali, sequentially adds volatile oil, carbomer, water are sufficiently mixed uniformly, make patch moulding material II;By patch forming material
Material II is mixed homogeneously and the most swelling with the quality ratio of 3.2:1 with patch moulding material I, makes patch, obtains treatment Lungs of Children
Scorching Chinese herbs paste;
The moulding material I of described patch is by following mass percent: drug component solution A 8.5%-13.5%, medicinal
Sodium polyacrylate 11%-16%, sodium carboxymethyl cellulose 2%-5.1%, pharmagel 2.2%-5.1%, tragacanth 1.3%-
2.1%, surplus is water, and total amount 100% forms;Patch moulding material II is by following mass percent: Cortex Phellodendri alkaloid
Solution 3%-5%, volatile oil 1%-5%, carbomer 19.3%-27.6%, surplus is water, and total amount 100% forms.
The Chinese herbs paste for the treatment of infantile pneumonia the most according to claim 1, it is characterised in that by the raw material of following weight meter
Medicine is made: Cortex Magnoliae Officinalis 71g, 71g Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae) 71g, Bulbus Fritillariae Thunbergii 71g, Flos Farfarae 71g, Caulis Lonicerae 71g, Herba Solani Nigri 71g, Rhizoma Zingiberis
71g, Cortex Phellodendri 91g, Flos Caryophylli 61g, Radix Bupleuri 71g, Herba Houttuyniae 81g, Herba Menthae 61g, wherein, by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, do
Rhizoma Zingiberis Recens mixes, with supercritical fluid extraction extract volatile oil, concretely comprise the following steps: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae,
Rhizoma Zingiberis mixes, and pulverizes, and puts into supercritical extraction unit, extracts according to following condition: extraction temperature 38 DEG C, extracting pressure 20MPa,
Extraction time 120min, CO2Flow 17L/h, extraction gained volatile oil is standby, and gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis,
Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A mix, and add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, money
Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, the ethanol that volumetric concentration is 70%-95% of medicinal residues A weight 10-16 times amount, carry with flash extracter
Taking 2 times, each 1-3min, filter, merging filtrate, 50 DEG C are evaporated to proportion is 1.06-1.12, and lyophilization obtains medicine
Component A, standby;Take Cortex Phellodendri pulverizing medicinal materials, add the ethanol solution that pH2.5 volumetric concentration is 50% of Cortex Phellodendri medical material weight 15 times
25 DEG C are soaked 8h, 95 DEG C of reflux, extract, 3h, filter, and filtrate reduced in volume to proportion is 1.08-1.15, highly acid sun on concentrated solution
Ion exchange resin, carries out eluting with the ethanol solution that volumetric concentration is 70% containing 1mol/L ammonia, and eluent is adjusted with hydrochloric acid
To pH6.5, concentrating under reduced pressure, lyophilization, obtain Cortex Phellodendri alkaloid extract, standby;Take drug component A and be dissolved in volumetric concentration and be
The ethanol of 5% is made the drug component solution A that mass concentration is 7%, is sequentially added into medical polypropylene acid sodium, carboxymethyl cellulose
Element sodium, pharmagel, tragacanth, water mix homogeneously, make patch moulding material I;Separately take Cortex Phellodendri alkaloid extract and be dissolved in body
Volume concentrations be 8% ethanol in make the Cortex Phellodendri alkaloid solution that mass concentration is 5%, sequentially add volatile oil, carbomer,
Water is sufficiently mixed uniformly, makes patch moulding material II;By patch moulding material II and patch moulding material I with the matter of 3.2:1
Measure than mix homogeneously the most swelling, make patch, the Chinese herbs paste of infantile pneumonia must be treated;
The moulding material I of described patch is by following mass percent: the acid of drug component solution A 8.5%, medical polypropylene
Sodium 11%, sodium carboxymethyl cellulose 2%, pharmagel 2.2%, tragacanth 1.3%, surplus is water, and total amount 100% forms;Patch
Agent moulding material II is by following mass percent: Cortex Phellodendri alkaloid solution 3%, volatile oil 1%, carbomer 19.3%,
Surplus is water, and total amount 100% forms.
The Chinese herbs paste for the treatment of infantile pneumonia the most according to claim 1, it is characterised in that by the raw material of following weight meter
Medicine is made: Cortex Magnoliae Officinalis 75g, 75g Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae) 75g, Bulbus Fritillariae Thunbergii 75g, Flos Farfarae 75g, Caulis Lonicerae 75g, Herba Solani Nigri 75g, Rhizoma Zingiberis
75g, Cortex Phellodendri 95g, Flos Caryophylli 65g, Radix Bupleuri 75g, Herba Houttuyniae 85g, Herba Menthae 65g, wherein, by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, do
Rhizoma Zingiberis Recens mixes, with supercritical fluid extraction extract volatile oil, concretely comprise the following steps: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae,
Rhizoma Zingiberis mixes, and pulverizes, and puts into supercritical extraction unit, extracts according to following condition: extraction temperature 38 DEG C, extracting pressure 20MPa,
Extraction time 120min, CO2Flow 17L/h, extraction gained volatile oil is standby, and gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis,
Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A mix, and add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, money
Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, the ethanol that volumetric concentration is 70%-95% of medicinal residues A weight 10-16 times amount, carry with flash extracter
Taking 2 times, each 1-3min, filter, merging filtrate, 50 DEG C are evaporated to proportion is 1.06-1.12, and lyophilization obtains medicine
Component A, standby;Take Cortex Phellodendri pulverizing medicinal materials, add the ethanol solution that pH2.5 volumetric concentration is 50% of Cortex Phellodendri medical material weight 15 times
25 DEG C are soaked 8h, 95 DEG C of reflux, extract, 3h, filter, and filtrate reduced in volume to proportion is 1.08-1.15, highly acid sun on concentrated solution
Ion exchange resin, carries out eluting with the ethanol solution that volumetric concentration is 70% containing 1mol/L ammonia, and eluent is adjusted with hydrochloric acid
To pH6.5, concentrating under reduced pressure, lyophilization, obtain Cortex Phellodendri alkaloid extract, standby;Take drug component A and be dissolved in volumetric concentration and be
The ethanol of 5% is made the drug component solution A that mass concentration is 7%, is sequentially added into medical polypropylene acid sodium, carboxymethyl cellulose
Element sodium, pharmagel, tragacanth, water mix homogeneously, make patch moulding material I;Separately take Cortex Phellodendri alkaloid extract and be dissolved in body
Volume concentrations be 8% ethanol in make the Cortex Phellodendri alkaloid solution that mass concentration is 5%, sequentially add volatile oil, carbomer,
Water is sufficiently mixed uniformly, makes patch moulding material II;By patch moulding material II and patch moulding material I with the matter of 3.2:1
Measure than mix homogeneously the most swelling, make patch, the Chinese herbs paste of infantile pneumonia must be treated;
The moulding material I of described patch is by following mass percent: drug component solution A 11.5%, medical polypropylene
Acid sodium 14%, sodium carboxymethyl cellulose 3.5%, pharmagel 3.5%, tragacanth 1.6%, surplus is water, total amount 100% group
Become;Patch moulding material II is by following mass percent: Cortex Phellodendri alkaloid solution 4%, volatile oil 3%, carbomer
23.5%, surplus is water, and total amount 100% forms.
The Chinese herbs paste for the treatment of infantile pneumonia the most according to claim 1, it is characterised in that by the raw material of following weight meter
Medicine is made: Cortex Magnoliae Officinalis 79g, 79g Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae) 79g, Bulbus Fritillariae Thunbergii 79g, Flos Farfarae 79g, Caulis Lonicerae 79g, Herba Solani Nigri 79g, Rhizoma Zingiberis
79g, Cortex Phellodendri 99g, Flos Caryophylli 69g, Radix Bupleuri 79g, Herba Houttuyniae 89g, Herba Menthae 69g, wherein, by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, do
Rhizoma Zingiberis Recens mixes, with supercritical fluid extraction extract volatile oil, concretely comprise the following steps: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae,
Rhizoma Zingiberis mixes, and pulverizes, and puts into supercritical extraction unit, extracts according to following condition: extraction temperature 38 DEG C, extracting pressure 20MPa,
Extraction time 120min, CO2Flow 17L/h, extraction gained volatile oil is standby, and gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis,
Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A mix, and add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, money
Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, the ethanol that volumetric concentration is 70%-95% of medicinal residues A weight 10-16 times amount, carry with flash extracter
Taking 2 times, each 1-3min, filter, merging filtrate, 50 DEG C are evaporated to proportion is 1.06-1.12, and lyophilization obtains medicine
Component A, standby;Take Cortex Phellodendri pulverizing medicinal materials, add the ethanol solution that pH2.5 volumetric concentration is 50% of Cortex Phellodendri medical material weight 15 times
25 DEG C are soaked 8h, 95 DEG C of reflux, extract, 3h, filter, and filtrate reduced in volume to proportion is 1.08-1.15, highly acid sun on concentrated solution
Ion exchange resin, carries out eluting with the ethanol solution that volumetric concentration is 70% containing 1mol/L ammonia, and eluent is adjusted with hydrochloric acid
To pH6.5, concentrating under reduced pressure, lyophilization, obtain Cortex Phellodendri alkaloid extract, standby;Take drug component A and be dissolved in volumetric concentration and be
The ethanol of 5% is made the drug component solution A that mass concentration is 7%, is sequentially added into medical polypropylene acid sodium, carboxymethyl cellulose
Element sodium, pharmagel, tragacanth, water mix homogeneously, make patch moulding material I;Separately take Cortex Phellodendri alkaloid extract and be dissolved in body
Volume concentrations be 8% ethanol in make the Cortex Phellodendri alkaloid solution that mass concentration is 5%, sequentially add volatile oil, carbomer,
Water is sufficiently mixed uniformly, makes patch moulding material II;By patch moulding material II and patch moulding material I with the matter of 3.2:1
Measure than mix homogeneously the most swelling, make patch, the Chinese herbs paste of infantile pneumonia must be treated;The moulding material of described patch
I by following mass percent: drug component solution A 13.5%, medical polypropylene acid sodium 16%, sodium carboxymethyl cellulose
5.1%, pharmagel 5.1%, tragacanth 2.1%, surplus is water, and total amount 100% forms;Patch moulding material II is by following
Mass percent: Cortex Phellodendri alkaloid solution 5%, volatile oil 5%, carbomer 27.6%, surplus is water, total amount 100% group
Become.
The Chinese herbs paste for the treatment of infantile pneumonia the most according to claim 1, it is characterised in that by the raw material of following weight meter
Medicine is made: Cortex Magnoliae Officinalis 78g, 72g Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae) 76g, Bulbus Fritillariae Thunbergii 73g, Flos Farfarae 77g, Caulis Lonicerae 79g, Herba Solani Nigri 71g, Rhizoma Zingiberis
72g, Cortex Phellodendri 98g, Flos Caryophylli 66g, Radix Bupleuri 76g, Herba Houttuyniae 87g, Herba Menthae 63g, wherein, by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae, do
Rhizoma Zingiberis Recens mixes, with supercritical fluid extraction extract volatile oil, concretely comprise the following steps: by Flos Caryophylli, Radix Bupleuri, Herba Houttuyniae, Herba Menthae,
Rhizoma Zingiberis mixes, and pulverizes, and puts into supercritical extraction unit, extracts according to following condition: extraction temperature 38 DEG C, extracting pressure 20MPa,
Extraction time 120min, CO2Flow 17L/h, extraction gained volatile oil is standby, and gained medicinal residues A weighs, standby;Cortex Magnoliae Officinalis, Radix Ophiopogonis,
Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, medicinal residues A mix, and add Cortex Magnoliae Officinalis, Radix Ophiopogonis, Semen Lepidii (Semen Descurainiae), Bulbus Fritillariae Thunbergii, money
Flos Farfarae, Caulis Lonicerae, Herba Solani Nigri, the ethanol that volumetric concentration is 70%-95% of medicinal residues A weight 10-16 times amount, carry with flash extracter
Taking 2 times, each 1-3min, filter, merging filtrate, 50 DEG C are evaporated to proportion is 1.06-1.12, and lyophilization obtains medicine
Component A, standby;Take Cortex Phellodendri pulverizing medicinal materials, add the ethanol solution that pH2.5 volumetric concentration is 50% of Cortex Phellodendri medical material weight 15 times
25 DEG C are soaked 8h, 95 DEG C of reflux, extract, 3h, filter, and filtrate reduced in volume to proportion is 1.08-1.15, highly acid sun on concentrated solution
Ion exchange resin, carries out eluting with the ethanol solution that volumetric concentration is 70% containing 1mol/L ammonia, and eluent is adjusted with hydrochloric acid
To pH6.5, concentrating under reduced pressure, lyophilization, obtain Cortex Phellodendri alkaloid extract, standby;Take drug component A and be dissolved in volumetric concentration and be
The ethanol of 5% is made the drug component solution A that mass concentration is 7%, is sequentially added into medical polypropylene acid sodium, carboxymethyl cellulose
Element sodium, pharmagel, tragacanth, water mix homogeneously, make patch moulding material I;Separately take Cortex Phellodendri alkaloid extract and be dissolved in body
Volume concentrations be 8% ethanol in make the Cortex Phellodendri alkaloid solution that mass concentration is 5%, sequentially add volatile oil, carbomer,
Water is sufficiently mixed uniformly, makes patch moulding material II;By patch moulding material II and patch moulding material I with the matter of 3.2:1
Measure than mix homogeneously the most swelling, make patch, the Chinese herbs paste of infantile pneumonia must be treated;
The moulding material I of described patch is by following mass percent: the acid of drug component solution A 8.7%, medical polypropylene
Sodium 15%, sodium carboxymethyl cellulose 2.2%, pharmagel 5.0%, tragacanth 1.4%, surplus is water, and total amount 100% forms;
Patch moulding material II is by following mass percent: Cortex Phellodendri alkaloid solution 3%, volatile oil 4.8%, carbomer
19.5%, surplus is water, and total amount 100% forms.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610832926.6A CN106166290A (en) | 2016-09-20 | 2016-09-20 | A kind of Chinese herbs paste treating infantile pneumonia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610832926.6A CN106166290A (en) | 2016-09-20 | 2016-09-20 | A kind of Chinese herbs paste treating infantile pneumonia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106166290A true CN106166290A (en) | 2016-11-30 |
Family
ID=57376409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610832926.6A Pending CN106166290A (en) | 2016-09-20 | 2016-09-20 | A kind of Chinese herbs paste treating infantile pneumonia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106166290A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102846842A (en) * | 2012-10-16 | 2013-01-02 | 河南中医学院 | Topical gel for treating rheumatic arthritis |
CN105125984A (en) * | 2015-08-21 | 2015-12-09 | 郑州市儿童医院 | Water-based external herbal plaster for treating infantile cough |
-
2016
- 2016-09-20 CN CN201610832926.6A patent/CN106166290A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102846842A (en) * | 2012-10-16 | 2013-01-02 | 河南中医学院 | Topical gel for treating rheumatic arthritis |
CN105125984A (en) * | 2015-08-21 | 2015-12-09 | 郑州市儿童医院 | Water-based external herbal plaster for treating infantile cough |
Non-Patent Citations (1)
Title |
---|
鞠燕鹏: "中西医结合治疗儿童支原体肺炎", 《山西中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102058673B (en) | Chinese medicine composition for expelling wind and removing dampness and preparation method thereof | |
CN107158223A (en) | For clearing heat and detoxicating Chinese medicine preparation with anti-inflammatory and preparation method thereof | |
CN105125984B (en) | A kind of aqueous Chinese medicine plaster for external application for treating infantile cough | |
CN101987166A (en) | Medicament for treating stye and preparation method thereof | |
CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
CN104547333B (en) | It is exclusively used in treating the Chinese medicine of diabetic nephropathy chronic renal failure | |
CN103071134A (en) | External preparation for treating rheumatic arthrodynia and traumatic pain and swelling and preparation method thereof | |
CN103028060B (en) | Traditional Chinese medicine composition for treating infant acute eczema and preparation method of traditional Chinese medicine composition | |
CN104524174A (en) | Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof | |
CN106166290A (en) | A kind of Chinese herbs paste treating infantile pneumonia | |
CN106728010A (en) | A kind of pharmaceutical composition and its preparation technology for livestock and poultry cough and asthma | |
CN106344680B (en) | A kind of Chinese medicine composition with wind and relieving paralysis effect of dispelling and preparation method thereof | |
CN112237604A (en) | Traditional Chinese medicine incense for reducing epidemic infection and preparation process thereof | |
CN103705599B (en) | A kind of pharmaceutical composition for the treatment of cough and preparation method thereof | |
CN113230293B (en) | Traditional Chinese medicine composition for dispelling wind and removing toxicity and preparation method thereof | |
CN102895507A (en) | Chinese medicine for treating leukoplakia vulvae and preparation method thereof | |
CN106692698B (en) | Bletilla striata cough relieving granule and preparation method thereof | |
CN108404009A (en) | One kind disappears pain injection for curing pharmaceutical composition and its preparation method and application | |
CN105288289A (en) | Traditional Chinese medicine composition for treating lung stroke | |
CN104083601A (en) | Traditional Chinese medicinal preparation for treating diabetes mellitus | |
CN104474120A (en) | Traditional Chinese medicine for treating long-term fever | |
CN104547695B (en) | It is a kind of for treating the pharmaceutical composition and its application of trigeminal neuralgia | |
CN112057587A (en) | Traditional Chinese medicine composition for gout and preparation method, external medicine and application thereof | |
CN102416160A (en) | Medicinal liquor for dispelling cold and warming body | |
CN103520499A (en) | Chinese herba preparation for treating wind-cold acute tracheobronchitis of childhood |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161130 |
|
WD01 | Invention patent application deemed withdrawn after publication |